Dana-Farber Cancer Institute Launches Neuro-Inclusive Oncology Care and Empowerment Program
Gordon J. Freeman, PhD, Recognized with 2024 AACR-Cancer Research Institute Lloyd J. Old Award in Cancer Immunology
Bispecific Antibody Therapies for Lymphoma
Pediatric Cancer Expert Explains New Options for Children With Sarcomas
Mapping a Path to Clinical Trials: Bringing Fox Chase’s Innovative Care to the Temple Community
Dana-Farber and Gustave Roussy to Hold Third Transatlantic Exchange: Annual Scientific Conference Dedicated to Advancing Oncology Research and Practice
BCL2 Inhibitors: What’s the Latest Research?
Dana-Farber Cancer Institute Researchers Join Global Cancer Grand Challenges Team Taking on Solid Tumors in Children
Fox Chase Fellows – Winter 2024
Many Legacies to Carry On
Laurie H. Glimcher, MD, Selected for STAT's 2024 STATUS List
Dana-Farber Researchers Receive AACR 2024 Scientific Achievement Awards
Dana-Farber CEO Laurie Glimcher Has Always Been a Trail-Blazer and a Risk-Taker
Antibody-Drug Conjugates: A Cancer Therapy Revolution
Preserving Laryngeal Structure and Function for Patients with Cancer
Showing 151 - 165 of 1043 results
Previous| 1... 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 ...70 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
